A Study Of EEG For Delirium Detection

Overview

About this study

The purpose of this study is to determine the acceptability of point-of-care EEG among healthcare providers and patients in a hospital setting. The goal of this aim is to assess the acceptability and satisfaction of healthcare providers (e.g., digital ambassadors, nurses, physicians) and patients with the use of point-of-care EEG technology. We will gather feedback through interviews to evaluate aspects such as ease of use, comfort, trust in the diagnostic results, and overall satisfaction. This will help identify barriers to adoption and areas for improvement in terms of both user experience and patient comfort.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age 60 and above.

  • Hospitalized at St Mary’s Hospital (observation or inpatient status)

 

Exclusion Criteria:

  • RASS +3 or greater.

  • RASS –4 or lower.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/28/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Allyson Palmer

Open for enrollment

Contact information:

Allyson Palmer

(507) 422-9316

Palmer.Allyson@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597179

Mayo Clinic Footer